1. Effects of nonoral estradiol–micronized progesterone or low-dose oral estradiol– drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause 
Gislaine Casanova, M.D., Simone Radavelli, M.Sc., Francisco Lhullier, Ph.D., Poli Mara Spritzer, M.D., Ph.D. 
Fertility and Sterility 
Volume 92, Issue 2, Pages (August 2009)
DOI: /j.fertnstert
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Markers of endothelial function and inflammation levels before and after 2 months of treatment (N = 40). Baseline: before the start of HT; Oral HT: low-dose oral E2 + drospirenone; Non-oral HT: nasal E2 + micronized P. Results presented as median and interquartile range. Values were log-converted for analysis and reconverted for presentation in figure format. ∗P=.01 versus baseline.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions